Samsrita Labs Ltd vs Trans India House Impex Ltd Stock Comparison
Samsrita Labs Ltd vs Trans India House Impex Ltd Stock Comparison
Last Updated on: Nov 01, 2026
Key Highlights
The Latest Trading Price of Samsrita Labs Ltd is ₹ 11.11 as of 30 Oct 15:30
. The P/E Ratio of Samsrita Labs Ltd changed from 28.5 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Trans India House Impex Ltd changed from 43.4 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 years The Market Cap of Samsrita Labs Ltd changed from ₹ 20.73 crore on March 2025 to ₹ 22.01 crore on March 2024 . This represents a CAGR of 1.00% over 6 yearsThe Market Cap of Trans India House Impex Ltd changed from ₹ 44.73 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 6 years The revenue of Samsrita Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.05 crore. This represent the decline of -100% The revenue of Trans India House Impex Ltd for the Jun '26 is ₹ 2 crore as compare to the Mar '26 revenue of ₹ 25.6 crore. This represent the decline of -92.19% The ebitda of Samsrita Labs Ltd for the Jun '26 is ₹ -0.31 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the growth of 158.33% The ebitda of Trans India House Impex Ltd for the Jun '26 is ₹ 0.37 crore as compare to the Mar '26 ebitda of ₹ 2.64 crore. This represent the decline of -85.98% The net profit of Samsrita Labs Ltd changed from ₹ -0.28 crore to ₹ -0.31 crore over 5 quarters. This represents a CAGR of 8.48%
The net profit of Trans India House Impex Ltd changed from ₹ 0.24 crore to ₹ -0.12 crore over 9 quarters. This represents a CAGR of NaN%
The Dividend Payout of Samsrita Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Trans India House Impex Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Samsrita Labs Ltd
Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996.
The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022.
Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own.
The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also.
In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.
About Trans India House Impex Ltd
Trans India House Impex Limited (TIHIL), formerly known as IO System Limited was incorporated on 25 May, 1987.
The name of the Company was changed from IO System Limited to Trans India House Impex Limited in 2022.
TIHIL is a dynamic and integrated international trade conglomerate, specializing in export, import, and merchant trading services.
TIHIL provides comprehensive end-to-end trade solution and are experts in market identification, product sourcing, and seamless transaction execution, ensuring efficient and profitable trade operations for the partners.
The core portfolio includes the trade of Ceramic Tiles, Textiles, Fabrics, and Fast-Moving Consumer Goods (FMCG).
In the initial years, Company had entered into a joint venture(JV) agreement with the General Binding Corporation (GBC), USA on 19 June, 1988 for manufacturing and selling office Automation products.
FAQs for the comparison of Samsrita Labs Ltd and Trans India House Impex Ltd
Which company has a larger market capitalization, Samsrita Labs Ltd or Trans India House Impex Ltd?
Market cap of Samsrita Labs Ltd is 25 Cr while Market cap of Trans India House Impex Ltd is 18 Cr
What are the key factors driving the stock performance of Samsrita Labs Ltd and Trans India House Impex Ltd?
The stock performance of Samsrita Labs Ltd and Trans India House Impex Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Samsrita Labs Ltd and Trans India House Impex Ltd?
As of November 1, 2026, the Samsrita Labs Ltd stock price is INR ₹11.11. On the other hand, Trans India House Impex Ltd stock price is INR ₹2.6.
How do dividend payouts of Samsrita Labs Ltd and Trans India House Impex Ltd compare?
To compare the dividend payouts of Samsrita Labs Ltd and Trans India House Impex Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.